AzTrials
AzTrials

DementiaSIRENSNCT07758738

Primary Care Screening and Intervention for Patients With Dementia and Caregivers

A study testing SIRENS application and SIRENS screening in people with Dementia and Elder Abuse, run by Weill Medical College of Cornell University at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The goal of this clinical trial is to evaluate the impact of screening for elder neglect in older adults with dementia in primary care settings and the impact of an intervention for caregivers of older adults with dementia. Read more about this study

Who is it for?
Ages 21 years and olderHealthy volunteers can take part
Conditions the study is for
Dementia, Elder Abuse, Elder Mistreatment
What is being tested?
SIRENS application and SIRENS screening
Could I receive a placebo?
No, everyone receives an active treatment
How many people
774 participants
Where
1 siteUnited States
Study dates
1 Nov 2026to 31 Jul 2027
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 21 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Primary care provider Inclusion Criteria • Active PCP who may be a physician or nurse practitioner seeing adult primary care patients with dementia at: Weill Cornell Medicine

Primary care provider Exclusion Criteria

  • Not a PCP of older adults with dementia who may be at risk of being neglected.

Older Adult Inclusion Criteria:

  • Aged ≥ 60 years
  • Community-dwelling
  • Patient of WCM/NYP
  • Has diagnosis of dementia (based on medical records prior to enrollment)
  • Requires assistance with at least 1 ADL
  • Able to travel to a WCM/NYP clinic for study activities
  • Has informal (either unpaid or CDPAP) caregiver who provides ≥8 hours weekly
  • Not already known to be experiencing neglect from caregiver

Older Adult Exclusion Criteria:

  • In hospice
  • Decision has already been made to re-locate to an institution (including long-term care skilled nursing facilities)

Caregiver Inclusion Criteria:

  • Age ≥ 21 years
  • Living with or near the older adult
  • Self-identifies as a caregiver for the older adult
  • Provides ≥ 8 hours per week of direct care (may include logistics, oversight, observation, as well as hands-on care, but must include at least some in-person assistance)
  • Able to travel to a WCM/NYP clinic for study activities or participate in study activities virtually through Zoom on their personal device
  • Not a professional caregiver, does not receive direct payment in return for care (unless through CDPAP)
  • Can read and speak English at a 6th grade level
  • No active plan to disengage from providing care to older adult within the next year

Caregiver Exclusion Criteria:

  • Unable to read and speak English at a 6th grade level
  • Hired/paid professional caregiver
  • Is blind or deaf
  • Active plan to disengage from providing care to older adult within the next year

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Chelsie Burchett, PhD contact

cob2014@med.cornell.edu

United States1 site
  • Weill Cornell Medicine

    New York, New York, 10065

    Sophie Park, sep4008@med.cornell.edu

Other trials in United States

About this study

Official title: Primary Care Screening and Intervention for Caregiving Assessment and Support for Patients With Dementia: Randomized Controlled Trial

The goal of this clinical trial is to evaluate the impact of screening for elder neglect in older adults with dementia in primary care settings and the impact of an intervention for caregivers of older adults with dementia.

The hypothesis of the study are:

Read more
  • Neglect screening in primary care will have a positive impact on outcomes including a decrease in presence of neglect at 6 months and other patient and caregiver outcomes
  • Neglect screening paired with a caregiving intervention will have a greater impact on these outcomes than screening alone

Researchers will compare three groups of participants to find out how effective the screening tool is on its own, and how effective it is when combined with the support program, compared to standard care.

Participants will be asked to:

  • attend primary care clinic visits
  • complete questionnaires
  • participate in the intervention
  • participate in a semi-structured interview
Being tested
SIRENS application, SIRENS screening
Medical subject headings
Dementia

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • SIRENS applicationBehavioural

    The SIRENS intervention is a technology intervention designed specifically for caregivers of those with dementia, providing them with easy access to expert-reviewed information and helpful resources. The content includes take-home messages summarizing the main points discussed and a goal-setting feature that encourages the care givers to establish small, actionable goals.

  • SIRENS screeningOther

    The SIRENS screening tool is a novel, easy-to-use, brief screening tool to identify elder neglect in primary care settings.

Study groups in NCT07758738
Study groupRoleWhat they receive
Screening and InterventionExperimentalNot described
Receives: Behavioral: SIRENS application; Other: SIRENS screening
Screening onlyActive comparatorNot described
Receives: Other: SIRENS screening
Usual careNo interventionNot described

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Percent change in number of participants with the presence of neglect determined by the Vulnerable Elder Protection Team (VEPT) from baseline at 6 months

    Caregiver abuse screen is a yes/no 8-question survey that asks about high stress and tendencies that could lead to future abuse. More "yes" answers indicate higher likelihood of current abuse and neglect, and future risk. The PCP Neglect Screening Questionnaire asks primary care providers for concern for caregiver neglect and level of concern using a 5-point scale. Higher scores indicate increased concern. Provider Observations survey asks for the primary care provider's subjective observations on the older adult's physical health. Electronic Health Record Data Elements survey extracts information from medical charts for hemoglobin, creatinine, and blood urea nitrogen lab results. Information from these surveys are used by the VEPT Expert Panel to determine presence of neglect.

    Measured: Baseline; 6 months

Secondary outcomes (11)
  1. Change in severity of neglect determined by the Vulnerable Elder Protection Team (VEPT) using the Health-Related Severity in Elder Neglect Scale from baseline at 6 months

    The VEPT Expert Panel's impression of the change in severity of neglect will be measured by the Health-Related Severity in Elder Neglect Scale. This scale asks providers two yes/no questions whether there is concern for caregiver neglect based on the screening tools and clinical assessment. If yes, their level of concern is asked based on the scale: Not Present; Not Present, Potential Risk; Present, Mild; Present, Moderate; and Present, Severe. There is no numerical or total score.

    Measured: Baseline; 6 months

  2. Mean change in score for caregiver burden from baseline at 6 months.

    Caregiver burden will be assessed in care partner participants using the reliable and valid Caregiver Burden Scale. Response options range from 0= Never to 4= Nearly always. Questions include those asking about relationship with the care recipient and stress. Overall scores range from 0 to 48, with higher scores indicating more caregiver burden.

    Measured: Baseline; 6 month

  3. Mean change in score of caregiver quality of life from baseline at 6 months

    Caregiver quality of life will be assessed in care partner participants using the reliable and valid Quality of Life Inventory survey. Questions include those asking about importance (on a 3-point rating scale, higher value indicating more importance) and satisfaction (on a 6-point rating scale, higher value indicating more satisfaction) of life domains. Importance scores are multiplied by satisfaction scores for each domain, and then these scores are summed to determine the overall score. Overall scores range from -96 to 96, with higher scores indicating higher quality of life.

    Measured: Baseline; 6 month

  4. Mean change in score of older adult quality of life from baseline at 6 months

    Older adult quality of life will be assessed in patients using the reliable and valid Quality of Life Dementia survey. Questions include those asking about subjective wellbeing using a 5-point rating scale across five domains: self-esteem, positive affect, negative affect, feelings of belonging, sense of aesthetics. Mean scores are computed for each domain, with high scores indicating more satisfaction (negative affect is reverse scored). Domain scores range from 1 to 5, with higher scores indicating higher quality of life. There is no total overall score.

    Measured: Baseline; 6 month

  5. Mean change in score of caregiver preparedness from baseline at 6 months

    Caregiver preparedness will be assessed in care partner participants using the Caregiver Preparedness Scale. Response options range from 0= Not at all prepared to 4= Very well prepared. Overall scores range from 0 to 24 with higher scores indicating more feelings of preparedness.

    Measured: Baseline; 6 month

  6. Mean change in score of caregiving self-efficacy from baseline at 6 months

    Caregiving self-efficacy will be measured in care partner participants by a modified Caregiving Self-Efficacy Scale. Response options range from 0= Can not do at all to 100= Certainly can do. Overall scores range from 0 to 900 with higher scores indicating more confidence.

    Measured: Baseline; 6 month

  7. Mean change in score of caregiver depression from baseline at 6 months

    Caregiver depression will be assessed in care partner participants using the reliable and valid Center for Epidemiologic Studies Depression Scale. Response options range from 0= Rarely or none of the time to 3= Most or almost none of the time. Overall scores range from 0 to 60 with higher scores indicating greater depressive symptoms.

    Measured: Baseline; 6 month

  8. Number of heath outcomes determined by medical chart review

    Number of each health outcome such as deaths, hospitalizations and use of medical services. Additional health-related outcomes will be included as identified.

    Measured: 6 month

  9. Count of the primary care provider's impression of the presence of neglect and severity of neglect measured by the Health-Related Severity in Elder Neglect Scale

    The primary care provider's impression of the presence of neglect and severity of neglect will be measured by the Health-Related Severity in Elder Neglect Scale. This scale asks providers two yes/no questions whether there is concern for caregiver neglect based on the screening tools and clinical assessment. If yes, their level of concern is asked based on the scale: Not Present; Not Present, Potential Risk; Present, Mild; Present, Moderate; and Present, Severe. There is no numerical or total score.

    Measured: Baseline; 6 month

  10. Number of individual actions taken after positive neglect screen determined by medical chart review

    Number of each individual action taken after positive neglect screen. Actions will be included as identified.

    Measured: Baseline; 6 month

  11. Change in technology acceptance score from post-intervention at 6 months

    Use of the intervention will be determined by the Technology Acceptance Scale which assesses system acceptance in two dimensions: a Usefulness scale and an affective Satisfying scale. Response options range from -2 to 2. Items 3, 6, and 8 are mirrored and should be scored -2..+2. The Usefulness scale is the sum of item 1 + 3 + 5 + 7 + 9 divided by 5, the Satisfying scale is the sum of items 2, 4, 6, and 8, divided by 4. Each scale has a total score that ranges from -2 to +2, with higher scores indicating more usefulness or satisfaction. The scales are not combined for a total score.

    Measured: Post-intervention (5 week); 6 month

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted11 Aug 2026
  2. Study start1 Nov 2026 (estimated)
  3. Primary completion31 Jul 2027 (estimated)
  4. Study completion31 Jul 2027 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
774 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07758738
Sponsor's protocol ID
24-09027919
Other IDs
4R33AG079012
Acronym
SIRENS
Status last verified
Aug 2026
First submitted
5 Aug 2026
Last updated
11 Aug 2026
Results posted
No
Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The investigators plan for resource sharing is based on the National Institutes of Health/National Institute on Aging (NIH/NIA) Data Sharing Policy. The investigators plan, consistent with the NIH goals of data sharing, is to promote use of the rich SIRENS database by the larger research community as this will further the impact of SIRENS and expand possibilities for collaboration. It will also allow other researchers to expedite the translation of the research findings into knowledge, products, and procedures. Further, the plan is devised to make the data as widely and freely available as possible while at the same time safeguarding the privacy of participants and protecting confidential and proprietary data.

Questions about this trial

What is this clinical trial studying?

A study testing SIRENS application and SIRENS screening in people with Dementia and Elder Abuse, run by Weill Medical College of Cornell University at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 11 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Sophie Park (6469627141, sep4008@med.cornell.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Percent change in number of participants with the presence of neglect determined by the Vulnerable Elder Protection Team (VEPT) from baseline at 6 months (time frame: Baseline; 6 months). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 11 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in